alexa Indicated and off-label use of Ranolazine


Cardiovascular Therapy: Open Access

Author(s): Mr Giuseppe Cocco

Abstract Share this page

Ranolazine is an anti-ischaemic agent that does not reduce heart rate nor blood pressure. It is approved as add-on therapy to conventional agents for the symptomatic treatment of patients with stable angina pectoris in whom conventional drugs have failed. Here, the author will describe its approved indications and studies and present its off-label use with a focus on the benefit ranolazine in a case of angina in the absence of coronary artery disease.

  • To read the full article Visit
  • Open Access
This article was published in e-journal of the ESC Council for Cardiology Practice and referenced in Cardiovascular Therapy: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version